PASITHEA THERAPEUTICS CORP.

Consensus Pasithea Therapeutics Corp.

Stocks

KTTA

US70261F2020

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 09:30:10 2026-09-08 EDT			5-day change	1st Jan Change
0.5750 ^USD	-0.86%		+1.05%	-55.04%

08-14	Pasithea Therapeutics Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-30	Pasithea Therapeutics Reports Positive Interim Phase 1 Advanced Cancer Study Data And Protocol Expansion	CI

Evolution of the Average Target: Pasithea Therapeutics Corp.

Evolution of the Target Price: Pasithea Therapeutics Corp.

Changes in Analyst Recommendations: Pasithea Therapeutics Corp.

0066c.BPoNTvYr0xxAAJDI5aIlPVuH7aoR7QH7CnMEWnFNHQs.RZxoCrJP5iQMcveqpNVpVi3hqdggr2yIYStHLz0CREV3r0d6z3GbUgZX5w~61a9f9235b1873e20006045228da9111

Analysts' recommendations: Pasithea Therapeutics Corp.

12-08	HC Wainwright Initiates Coverage on Pasithea Therapeutics With Buy Rating, $3 Price Target	MT
23-04-03	EF Hutton Adjusts Price Target on Pasithea Therapeutics to $2 From $2.30, Maintains Buy Rating	MT

More recommendations

Bio Therapeutic Drugs

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	PASITHEA THERAPEUTICS CORP.			-	-	+417.24%
	WUXI APPTEC CO., LTD.					+22.07%
	ARGENX SE					+15.8%
	INSMED INCORPORATED					+58.51%
	BIONTECH SE					+15.94%
	WUXI BIOLOGICS (CAYMAN) INC.					+19.01%
	GENMAB A/S					+14.61%
	PHARMAESSENTIA CORPORATION					+5.45%
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.					+26.11%
	EXELIXIS, INC.					-9.02%
	Average					+58.57%
	Weighted average by Cap.					+20.44%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

0.5800USD

Average target price

3.000USD

Spread / Average Target

+417.24%

High Price Target

3.000USD

Spread / Highest target

+417.24%

Low Price Target

3.000USD

Spread / Lowest Target

+417.24%

Analyst Consensus Detail

Consensus revision (last 18 months)

Stock Market
Stocks
KTTA Stock
Consensus Pasithea Therapeutics Corp.

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!

SEIZE THE OFFER!